[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":16801000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":306000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":3041000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":103823000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":134968000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue_0_Q2_USD":40700.0,"LongTermDebtCurrent_0_Q2_USD":1750000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-4000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":226000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-39471000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-20491000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":574385000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":1774000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":134924000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":134924000.0,"OtherAssetsNoncurrent_0_Q2_USD":1844000.0,"OperatingLeasesRentExpenseNet_2_Q2_USD":900000.0,"OperatingLeasesRentExpenseNet_1_Q2_USD":600000.0,"NonoperatingIncomeExpense_2_Q2_USD":1676000.0,"NonoperatingIncomeExpense_1_Q2_USD":686000.0,"LongTermDebtNoncurrent_0_Q2_USD":5750000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":1756000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":134000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":5705000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2552000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":204111000.0,"RestrictedCash_0_Q2_USD":210000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":96818000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":226000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":-4000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.055,"OperatingLeaseRightOfUseAsset_0_Q2_USD":7108000.0,"OperatingLeasePayments_2_Q2_USD":100000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":6019000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1745000.0,"OperatingLeaseLiability_0_Q2_USD":7763000.0,"InterestAndOtherIncome_2_Q2_USD":1937000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":1086000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":2141000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":2098000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":2080000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":1558000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":722000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":8849000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":-71000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-533000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff_2_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":108833000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":250000.0,"RestrictedCashNoncurrent_0_Q2_USD":210000.0,"InterestAndOtherIncome_1_Q2_USD":818000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":104000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":5774000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":137615000.0,"LiabilitiesCurrent_0_Q2_USD":18551000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":353000000.0,"Liabilities_0_Q2_USD":30626000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":367000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":15101000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":7476000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.82,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.4,"Depreciation_2_Q2_USD":12000.0,"CommonStockValue_0_Q2_USD":6000.0,"CommonStockSharesOutstanding_0_Q2_shares":56214000.0,"CommonStockSharesIssued_0_Q2_shares":56214000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":134758000.0,"AssetsCurrent_0_Q2_USD":342186000.0,"Assets_0_Q2_USD":353000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":5141000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":5141000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":557000.0,"AccountsPayableCurrent_0_Q2_USD":786000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-34556000.0,"NetIncomeLoss_1_Q2_USD":-20487000.0,"NetIncomeLoss_2_Q2_USD":-39697000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1231000.0,"ShareBasedCompensation_2_Q2_USD":5705000.0,"ShareBasedCompensation_1_Q2_USD":2552000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":26272000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":13697000.0,"PreferredStockValue_0_Q2_USD":null,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OperatingExpenses_2_Q2_USD":41373000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-537000.0,"OperatingExpenses_1_Q2_USD":21173000.0,"InterestExpense_1_Q2_USD":144000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":48522000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":51633000.0,"StockholdersEquity_0_Q2_USD":322374000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-252574000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1652000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":135180000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3317000.0,"InterestExpense_2_Q2_USD":288000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":7500000.0,"Ticker":"KURA","CIK":"1422143","name":"KURA ONCOLOGY, INC.","OfficialName":"Kura Oncology Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1071823749.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]